All posts by tag
GEROPHARM
GEROPHARM is one of the leaders in the field of biotechnology products used for diabetes treatment. Company is specializing in full-cycle drug development and production of insulin products (rh-insulins, insulin glargine, lispro & lispro mix, aspart & aspart mix, degludec).
GEROPHARM expertise also covers neurology, ophthalmology, endocrinology and gynecology therapeutic areas. GEROPHARM production facilities (two manufacturing plants) fully comply with ISO 9001 and GMP standard.
GEROPHARM is going to develop biomedicine and pharmacology in the Russian Far East
GEROPHARM has successfully passed Cuba’s GMP audit
GEROPHARM brings back Ozempic® with a new name: Semavic®
GEROPHARM invests 2 billion roubles in medicinal product manufacture in Saint Petersburg
GEROPHARM will localize the production of 300 IU/mL insulin glargine in Kazakhstan
Algeria released the first batch of insulins from GEROPHARM pharmaceutical substance
Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.